NEONATAL ASPHYXIA

This adverse event was reported 709 times

These drugs are most commonly taken by patients reporting NEONATAL ASPHYXIA:

# Drug Count
0 VENLAFAXINE HYDROCHLORIDE 58
1 VENLAFAXINE 56
2 QUETIAPINE 38
3 LAMOTRIGINE 30
4 MIRTAZAPINE 28
5 SERTRALINE 27
6 LAMOTIRIGINE 25
7 LAMOTRIGINE CHEWABLE DISPERSIBLE 25
8 LAMOTRIGINE EXTENDED-RELEASE 25
9 PROGESTERONE 25
See all common drugs associated with NEONATAL ASPHYXIA

NEONATAL ASPHYXIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 NALBUPHINE HYDROCHLORIDE 10 0.0439
1 DINOPROSTONE 23 0.0280
2 PAROMOMYCIN SULFATE 2 0.0189
3 EPHEDRINE HYDROCHLORIDE 4 0.0088
4 PORACTANT ALFA 6 0.0081
5 ARTEMETHER AND LUMEFANTRINE 1 0.0051
6 OXYTOCIN 15 0.0049
7 MEBENDAZOLE 3 0.0038
8 MEPIVACAINE HYDROCHLORIDE 4 0.0035
9 METHYLDOPA 14 0.0028
See all drugs enriched for association with NEONATAL ASPHYXIA

NEONATAL ASPHYXIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Surfactant [EPC] 6 0.0052
1 Oxytocic [EPC] 15 0.0049
2 Prostacycline [EPC] 2 0.0021
3 Adrenal Steroid Synthesis Inhibitor [EPC] 2 0.0020
4 Prostaglandin E1 Analog [EPC] 23 0.0014
5 Carbamoyl Phosphate Synthetase 1 Activator [EPC] 1 0.0013
6 Progesterone [EPC] 25 0.0011
7 Anthelmintic [EPC] 3 0.0010
8 Provitamin D2 Compound [EPC] 28 0.0009
9 alpha-1 Adrenergic Agonist [EPC] 3 0.0007
See all drug classes enriched for association with NEONATAL ASPHYXIA